NYC’s Leading Integrative Health Care Center

Anti-Aging and Longevity Treatments Remember when you were in college and stayed up all night drinking beer, eating pizza, and partying; yet you still were able to attend class in the morning? How many of you could do that now?
General allergies arise when the immune system’s regulatory circuits misfire — producing an exaggerated IgE-mediated response to harmless substances that floods your body with histamine, triggers systemic inflammation, and disrupts sleep, concentration, and quality of life far beyond a seasonal runny nose. If you feel like you are allergic to the world, there is a root-cause reason, and it can be found.
of U.S. adults have allergic rhinitis
Americans affected by allergies annually
typical immunotherapy course for desensitisation
leading cause of chronic illness in the U.S.
Board-certified integrative medicine physician.
General allergies — also termed allergic hypersensitivity disorders or atopic disease — are immune-mediated conditions in which sensitised individuals mount an aberrant, IgE-mediated Type I hypersensitivity reaction upon re-exposure to specific environmental antigens (allergens), including aeroallergens such as pollens, house dust mite (Dermatophagoides pteronyssinus), mold spores, animal dander, insect venoms, and latex. Mast cell and basophil degranulation releases histamine, leukotrienes (LTC4, LTD4), prostaglandins (PGD2), and cytokines (IL-4, IL-5, IL-13), producing the acute and late-phase allergic responses. In functional medicine, chronic allergic reactivity is understood to reflect a systemic immune dysregulation pattern, frequently driven by intestinal hyperpermeability, microbiome depletion, HPA-axis dysregulation, and micronutrient insufficiency, rather than a fixed genetic destiny.
General allergies are a category of immune-system disorders in which the body develops an exaggerated sensitivity to substances — called allergens — that would cause no reaction in most people. Common environmental allergens include tree, grass, and weed pollens; house dust mites; cat and dog dander; Alternaria and Aspergillus mold spores; and cockroach proteins. When a sensitised person encounters their specific allergen, the immune response is not simply proportionate — it is dramatically amplified, flooding tissues with inflammatory chemicals that can affect the nose, eyes, skin, lungs, and gastrointestinal tract simultaneously.
The biological mechanism begins with sensitisation: on first allergen exposure, antigen-presenting dendritic cells in the nasal or bronchial mucosa present allergen fragments to T-helper-2 (Th2) lymphocytes. These Th2 cells release interleukin-4 (IL-4) and interleukin-13 (IL-13), signalling B-cells to class-switch and produce allergen-specific immunoglobulin E (IgE) antibodies. These IgE molecules bind to high-affinity receptors (FcεRI) on mast cells throughout the body. On re-exposure, allergens cross-link these membrane-bound IgE antibodies, triggering instantaneous mast cell degranulation — a surge of histamine, prostaglandins, and leukotrienes that causes the familiar allergy symptoms within minutes.
From a functional medicine perspective, the critical question is not just “what are you allergic to?” but “why is your immune system hyper-reactive in the first place?” Decades of research point to the gut-immune axis as the central regulator of allergic reactivity. Approximately 70% of the immune system resides in the gut-associated lymphoid tissue (GALT). When the intestinal barrier is compromised — a condition called increased intestinal permeability or leaky gut — incompletely digested food proteins and bacterial endotoxins (lipopolysaccharides) cross into the bloodstream, chronically stimulating the immune system into a state of vigilance that amplifies all allergic reactions. Additionally, depletion of key regulatory T-cells (Tregs) — which normally act as the immune system’s “off switch” — allows allergic Th2 responses to run unchecked. Restoring gut integrity and Treg function is therefore as important as allergen avoidance in achieving lasting allergy remission.
Allergic diseases affect an estimated 50 million Americans and constitute the sixth leading cause of chronic illness in the United States, costing over $18 billion annually in direct medical costs. The prevalence of allergic rhinitis has more than doubled since the 1970s, a rise that cannot be explained by genetics alone and strongly implicates environmental, dietary, and microbiome changes. Women are slightly more likely than men to develop adult-onset allergies; however, children with atopic eczema, asthma, and food allergies have a significantly elevated lifetime risk of developing additional allergic conditions — a phenomenon known as the atopic march.
Mast cells reside in virtually every body tissue, particularly at interfaces with the environment — nasal mucosa, skin, and gut lining. Covered with 100,000–500,000 surface IgE receptors (FcεRI), a single sensitised mast cell can degranulate instantaneously on allergen contact, releasing pre-formed histamine and synthesising leukotrienes and prostaglandins that produce the acute allergic response.
In healthy immune regulation, Th1 and Th2 lymphocyte activity is balanced. Allergic individuals have a Th2-dominant phenotype in which excess IL-4, IL-5, and IL-13 production drives IgE synthesis, eosinophil recruitment, and mucus secretion. Functional medicine aims to restore Th1/Th2 balance — and enhance Treg suppressor activity — through gut microbiome optimisation and targeted anti-inflammatory nutrition.
The respiratory mucosal barrier is the primary point of allergen contact. In sensitised individuals, this barrier is structurally compromised — tight junctions are loosened by IL-25 and TSLP (thymic stromal lymphopoietin), allowing larger allergen particles to penetrate and stimulate deeper immune cells. Chronic allergic rhinitis creates persistent mucosal oedema, sinus ostial blockage, and an inflammatory milieu that predisposes to secondary bacterial sinusitis and asthma.
Allergic immune activation is systemic — far beyond seasonal sneezing — affecting the respiratory, neurological, dermatological, and gastrointestinal systems simultaneously through shared histamine and cytokine pathways.
Histamine stimulates mucus gland secretion in the nasal turbinates, producing the characteristic watery nasal discharge that intensifies on allergen exposure.
Vascular dilation and submucosal oedema caused by prostaglandin D2 (PGD2) and leukotrienes narrow the nasal airway, reducing airflow and causing the blocked sensation.
Allergen stimulation of trigeminal sensory nerve endings in the nasal epithelium triggers repetitive sneezing reflexes as the body attempts to expel the perceived threat.
Excess nasal mucus drains posteriorly, coating the pharynx and larynx, triggering persistent throat-clearing and a chronic dry or productive cough.
Allergic mucosal oedema blocks the ostiomeatal complex — the drainage pathway of the paranasal sinuses — creating stagnant secretions that are readily colonised by bacteria.
Eustachian tube dysfunction secondary to nasopharyngeal oedema impairs middle ear pressure equalisation, producing a sensation of fullness or muffled hearing.
IgE-mediated mast cell activation in the conjunctival mucosa produces bilateral itching, redness, tearing, and chemosis (conjunctival swelling) on allergen exposure.
Chronic nasal and periorbital venous congestion produces darkening and puffiness under the eyes — a classic sign of persistent allergen exposure or food intolerance.
Dermal mast cell degranulation produces localised wheals with surrounding flare (redness) through histamine-mediated vasodilation and plasma extravasation into skin tissues.
A Th2-driven inflammatory skin condition in which epidermal barrier defects allow allergen penetration, producing the intensely pruritic, inflamed, and lichenified patches typical of atopic eczema.
Deep dermal and subcutaneous swelling, most commonly affecting the lips, eyelids, tongue, and throat, caused by bradykinin- or histamine-driven fluid extravasation into deeper tissue layers.
Elevated systemic histamine levels activate H1 receptors on cutaneous sensory nerve endings, producing diffuse itching even in the absence of visible rash or hives.
Pro-inflammatory cytokines IL-1β and TNF-α cross the blood-brain barrier and impair prefrontal cortex function, reducing working memory, concentration, and processing speed.
Persistent immune activation diverts metabolic energy toward cytokine production and tissue repair, directly reducing cellular ATP availability and driving the profound tiredness that allergy sufferers describe.
Sinus congestion elevates intrasinusal pressure and can refer pain across the forehead, cheeks, and orbital ridges — distinct from migraine but equally debilitating.
Histamine is a key wakefulness-promoting neurotransmitter in the hypothalamic tuberomammillary nucleus; high systemic histamine levels disrupt normal sleep architecture and cause non-restorative sleep.
Neuroinflammatory signalling via the vagus nerve — the gut-brain axis — translates peripheral immune activation into central nervous system effects including increased anxiety and depressive symptoms.
Gut mast cells activated by food allergens or high systemic histamine levels impair gastric motility, increase intestinal secretions, and produce cramping, bloating, and nausea.
Histamine acting on H1 and H2 receptors in the intestinal mucosa increases intestinal motility and secretion, accelerating gastrointestinal transit and causing loose stools in sensitised individuals.
Leukotriene-mediated bronchospasm and mucus hypersecretion in the lower respiratory tract produces the characteristic wheeze and dyspnoea of allergic asthma — a common comorbidity of allergic rhinitis.
Pyrogenic cytokines (particularly IL-1β and IL-6) produced during significant allergic reactions can generate a mild fever and the systemic flu-like malaise that distinguishes severe allergy from a simple seasonal flare.
Chronic histamine elevation disrupts appetite regulation via hypothalamic H1 receptors, and systemic inflammation impairs insulin sensitivity and thyroid function, contributing to unexplained weight gain in allergy sufferers.
Understanding your allergy type determines which tests, treatments, and environmental modifications will be most effective in reducing your immune reactivity.
Triggered by airborne pollens from trees (spring), grasses (summer), and weeds (autumn), seasonal allergic rhinitis produces predictable cyclical flares of rhinorrhoea, sneezing, and conjunctivitis. IgE levels against specific pollens are elevated; total IgE may be moderately raised.
This is the most common allergy type. Skin prick testing readily identifies the offending pollens, and patients often have a clear on/off pattern mirroring regional pollen calendars.
Year-round allergic rhinitis driven by indoor allergens — most commonly house dust mites (Dermatophagoides pteronyssinus), cockroach allergens, cat (Fel d 1) and dog (Can f 1) dander, and Aspergillus and Alternaria molds. Symptoms are constant rather than seasonal, and nasal congestion tends to dominate over rhinorrhoea.
Perennial rhinitis frequently co-occurs with asthma and eczema, and patients are at higher risk of developing chronic sinus disease.
↳ Affects all ages; pet ownership and poor indoor air quality are major risk factors.
Allergic reactions to mold spores are common (seasonal outdoor molds, indoor water-damage molds), but a distinct and underdiagnosed problem is mycotoxin sensitivity — an inflammatory response to biotoxins produced by molds including Stachybotrys chartarum (black mold), Aspergillus, and Penicillium. Mycotoxins trigger IgE- and IgG-mediated reactions and can persist long after allergen removal.
Mold-sensitive patients frequently report extreme fatigue, cognitive dysfunction, and multiple chemical sensitivities that extend beyond respiratory symptoms.
↳ Particularly prevalent in NYC residents in older buildings with water damage history.
Polysensitisation — IgE-mediated reactivity to four or more unrelated allergen categories simultaneously — represents the most immunologically complex and clinically challenging allergy phenotype. It is strongly associated with gut dysbiosis, intestinal hyperpermeability, and impaired Treg regulation. Patients frequently have concurrent asthma, eczema, food allergies, and chemical sensitivities.
Functional medicine is particularly well-suited to this category because the root-cause approach addresses the systemic immune dysregulation driving reactivity to multiple allergens simultaneously.
↳ More common in patients with prior antibiotic exposure, c-section birth, or early formula feeding.
Allergic disease results from a convergence of multiple interacting drivers — genetic predisposition, immune dysregulation, environmental exposures, and lifestyle factors — rather than a single trigger.
Reduced microbial diversity — particularly loss of Lactobacillus rhamnosus, Bifidobacterium longum, and Faecalibacterium prausnitzii — impairs immune tolerance by reducing short-chain fatty acid (SCFA) production and Treg cell differentiation in the intestinal mucosa.
Disrupted tight junction proteins (occludin, claudin, ZO-1) allow undigested food antigens and bacterial LPS to enter systemic circulation, chronically stimulating IgE and IgG production and priming the immune system for heightened reactivity.
Broad-spectrum antibiotics (particularly ampicillin, amoxicillin-clavulanate) dramatically reduce gut microbial diversity, suppressing SCFA production and impairing mucosal IgA secretion that normally neutralises inhaled allergens before immune sensitisation occurs.
Airborne spores and volatile organic compounds (VOCs) from water-damaged buildings directly activate mast cells through non-IgE pathways and induce pulmonary and systemic inflammation that amplifies all concurrent allergic reactivity.
HPA axis activation elevates cortisol, which initially suppresses immune activity; however, chronic cortisol exposure causes glucocorticoid receptor resistance, impairing cortisol’s anti-inflammatory action and shifting the immune system toward Th2 pro-allergic activation.
Dietary emulsifiers (polysorbate-80, carboxymethylcellulose) disrupt the intestinal mucus layer; artificial colorants and preservatives activate mast cells directly; and low-fibre diets deplete butyrate-producing bacteria critical to mucosal immune tolerance.
Caesarean birth (bypassing maternal vaginal microbiota transfer), exclusive formula feeding (limiting immune-modulating oligosaccharides), and overly sanitised early environments collectively impair the immune education that normally establishes tolerogenic responses.
Cadmium, arsenic, and mercury directly impair Treg function and enhance mast cell sensitivity; airborne particulate matter (PM2.5) acts as an adjuvant that enhances IgE responses to co-inhaled allergens — a significant factor for NYC urban residents.
The modern Western diet provides an omega-6/omega-3 ratio of 15:1 to 20:1, far exceeding the ancestral 4:1 ratio, driving prostaglandin E2 (PGE2) dominance that actively promotes mast cell sensitivity and Th2 immune skewing.
DAO is the primary enzyme responsible for degrading dietary and endogenous histamine in the intestinal mucosa; deficiency — caused by nutrient deficiencies (copper, vitamin B6, vitamin C) or gut mucosal damage — leads to systemic histamine accumulation that dramatically amplifies allergic symptoms.
Many conditions share symptom overlap with general allergies, and correct differentiation is essential for appropriate testing and treatment. The following comparison highlights the key distinguishing features.
| Feature | General Allergies | Food Allergies / Intolerance | Mast Cell Activation Syndrome (MCAS) | Chronic Sinusitis |
|---|---|---|---|---|
| Key immune marker | Elevated specific IgE (aeroallergens) | Elevated food-specific IgE or IgG | Elevated serum tryptase, prostaglandin D2, histamine | CT findings of mucosal thickening; often normal IgE |
| Best diagnostic test | IgE RAST panel + skin prick test | IgE RAST + comprehensive IgG food panel | 24-hour urine prostaglandin D2 + serum tryptase | Sinus CT scan + endoscopic evaluation |
| Hallmark symptom | Sneezing, rhinorrhoea, conjunctivitis on allergen exposure | GI symptoms (IgE) or delayed bloating/fatigue (IgG) after eating | Flushing, tachycardia, diarrhoea triggered by multiple unrelated stimuli | Persistent facial pressure, purulent discharge, anosmia |
| Standard blood test detects it? | Partially (total IgE, CBC eosinophils) | Rarely (IgG panels are non-standard) | Often missed on standard panels | May show elevated CRP/ESR; normal IgE |
| Treatment approach | Allergen immunotherapy + gut-immune repair | Elimination diet + gut barrier restoration | Mast cell stabilisers + low-histamine diet | Saline irrigation + antibiotics; surgery for anatomical causes |
| Overlap with other condition | Frequently co-occurs with all three conditions | Often underlies or worsens general allergies | May be misdiagnosed as general allergies for years | Untreated allergic rhinitis is the leading sinusitis driver |
Important clinical note: Mast Cell Activation Syndrome (MCAS) is a frequently missed diagnosis in patients labelled with “severe allergies.” Unlike classic IgE-mediated allergy, MCAS involves constitutive mast cell instability triggered by multiple unrelated stimuli (temperature, vibration, medications, emotional stress), producing systemic symptoms across 10 or more organ systems. If your symptoms are disproportionately severe, occur without a clear allergen trigger, or do not respond to standard allergy treatment, ask your physician about MCAS evaluation.
There is an important ongoing clinical debate about the scope of allergic disease — specifically whether immune reactions beyond the classic IgE-mediated pathway deserve medical attention, and what role gut health plays. Understanding both perspectives helps you advocate for comprehensive care.
Patients Medical’s Position: We respect and incorporate conventional allergy medicine — skin prick testing, RAST panels, and allergen immunotherapy are valuable tools we use regularly. We also recognise that these tools, used in isolation, do not identify or address the underlying immune dysregulation that makes a person allergic in the first place. Our approach combines the precision of conventional allergy diagnosis with functional medicine’s root-cause framework — evaluating gut integrity, microbiome health, nutrient status, toxic exposures, and stress physiology — to achieve outcomes that neither approach can deliver alone.
Our comprehensive allergy evaluation goes far beyond a standard RAST panel — mapping the full terrain of immune reactivity and identifying every upstream driver.
The IgE RAST panel measures serum immunoglobulin E antibody levels against 120+ individual environmental allergens — including regional tree, grass, and weed pollens; house dust mite species (D. pteronyssinus and D. farinae); common mold species (Aspergillus fumigatus, Alternaria alternata, Cladosporium herbarum); cat (Fel d 1), dog (Can f 1), and cockroach allergens; and insect venoms. This test definitively identifies IgE-mediated sensitisation and quantifies each reaction, guiding the formulation of custom immunotherapy protocols.
While not a test for classic IgE food allergy, the IgG food sensitivity panel identifies delayed immune reactions to specific foods that chronically stimulate gut mast cells and drive systemic immune activation. Elevated IgG reactivity to foods such as gluten (gliadin), casein (dairy), eggs, corn, soy, and yeast is extraordinarily common in allergy patients and frequently contributes to the total inflammatory load that makes environmental allergy symptoms more severe. Eliminating high-IgG foods allows gut mucosal healing and often produces significant reduction in environmental allergy severity within 6–8 weeks.
The CBC with differential provides objective evidence of allergic immune activation through elevated eosinophil count (normal: <0.5 × 10⁹/L) and basophil count. Peripheral eosinophilia (eosinophil count >0.5) is a biomarker of active allergic inflammation and is also seen in parasitic infections and eosinophilic GI conditions that can mimic allergy. Tracking eosinophil count over the course of treatment provides a measurable indicator of immune calming and treatment response
Mold toxin (mycotoxin) urine testing measures urinary levels of 11 mycotoxins including ochratoxin A, aflatoxins, trichothecenes (satratoxins), zearalenone, and gliotoxin. These biotoxins, produced by common indoor molds including Stachybotrys, Aspergillus, and Penicillium species, are not detected by standard IgE mold testing but are a significant driver of severe, treatment-resistant allergies in NYC patients living or working in older buildings. Positive mycotoxin results guide environmental remediation and targeted binder therapy with cholestyramine or activated charcoal.
The GI-MAP comprehensive stool test uses quantitative PCR technology to measure the abundance of commensal bacteria, opportunistic pathogens, parasites, Candida, and H. pylori in the gut microbiome, along with secretory IgA (mucosal immunity marker), calprotectin (intestinal inflammation marker), anti-gliadin IgA (gluten reactivity), and elastase-1 (pancreatic enzyme sufficiency). Identifying specific bacterial depletions and pathogenic overgrowth allows a targeted gut restoration protocol that addresses the microbiome root cause of immune dysregulatio
Check all that apply to your current experience:
Our treatment protocol is built on a single guiding principle: lasting allergy relief requires addressing the root causes of immune dysregulation, not simply suppressing symptoms.
The foundation of allergy treatment at Patients Medical is rebuilding the gut microbiome environment that regulates immune tolerance. Based on your GI-MAP results, we prescribe a targeted protocol of specific probiotic strains — typically including Lactobacillus rhamnosus GG, Lactobacillus acidophilus NCFM, Bifidobacterium longum BB536, and Faecalibacterium prausnitzii precursors — combined with prebiotic fibres (partially hydrolysed guar gum, arabinogalactans) and gut mucosal repair nutrients (L-glutamine, zinc carnosine, deglycyrrhizinated licorice) to restore intestinal barrier integrity and re-establish Treg-mediated immune tolerance.
High-dose intravenous vitamin C (15–50g per infusion) provides immediate and potent natural antihistamine activity by accelerating histamine degradation via the enzyme histamine-N-methyltransferase, while simultaneously reducing mast cell reactivity through antioxidant-mediated stabilisation of mast cell membranes. Paired with intravenous glutathione (600–1200mg), which replenishes the master antioxidant depleted by chronic inflammation, our IV vitamin therapy protocol produces rapid symptom relief and a gradual reduction in baseline immune reactivity over a course of 6–10 infusions.
Based on your comprehensive lab results, we design a personalised nutraceutical protocol targeting the specific mechanisms driving your allergic reactivity. Core agents include quercetin (500–1000mg daily) as a natural mast cell stabiliser; vitamin D3 (titrated to achieve serum 25-OH-D of 60–80 ng/mL) to restore Treg-mediated immune tolerance; EPA/DHA omega-3 fatty acids (2–3g daily) to shift prostaglandin synthesis away from pro-inflammatory PGE2; butterbur extract (standardised to petasines) for acute rhinitis relief; and diamine oxidase (DAO) enzyme supplementation for patients with documented histamine intolerance.
For patients with positive mycotoxin testing or heavy metal burden, we implement a structured environmental detoxification protocol. This includes medical-grade binders — cholestyramine, activated charcoal, or bentonite clay — to sequester circulating mycotoxins; chelation therapy for patients with documented heavy metal toxicity; comprehensive guidance on air filtration (HEPA + activated carbon), water filtration, and building inspection for water damage; and VCS (visual contrast sensitivity) testing and MARCoNS nasal culture for patients with suspected biotoxin illness.
Based on your IgG food sensitivity results and clinical presentation, we implement a structured elimination diet that removes the specific foods generating your highest IgG immune reactions for a minimum of 6 weeks — long enough for intestinal mucosa regeneration (complete mucosal cell turnover takes approximately 5–7 days; however, inflammation resolution and IgG antibody clearance require 4–6 weeks). Following the elimination phase, foods are systematically reintroduced at 3-day intervals to identify which specific foods perpetuate symptoms, creating a personalised long-term eating map.
Because chronic HPA-axis activation drives mast cell priming and impairs glucocorticoid receptor sensitivity — directly worsening allergic reactivity — stress regulation is a clinical intervention, not an optional lifestyle suggestion. Our protocol includes assessment of salivary cortisol diurnal pattern (4-point testing), adaptogenic herbal medicine (ashwagandha, rhodiola, eleuthero) dosed to your specific cortisol pattern, targeted neurotransmitter support (GABA, L-theanine, phosphatidylserine) for patients with high evening cortisol, and referral for evidence-based mind-body interventions including HeartMath biofeedback and mindfulness-based stress reduction (MBSR).
| Weeks 1–2 | Comprehensive testing completed, initial dietary changes implemented, gut support protocol initiated. Many patients notice reduced symptom severity within the first 2–3 weeks as food triggers are removed. |
| Weeks 4–8 | IV therapy sessions begin; nutraceutical protocol fully implemented; mycotoxin/heavy metal detoxification protocol commenced where indicated. Most patients report 40–60% reduction in overall allergy burden by week 8. |
| Months 3–6 | Gut microbiome rebalancing consolidates; immune Th2-to-Th1 recalibration becomes measurable on repeat eosinophil counts and IgE levels. Patients typically experience significant improvement in sleep, energy, and cognitive clarity as the systemic inflammatory load reduces. |
| Months 6–12 | Most patients achieve stable, durable improvement with maintenance doses of key supplements and dietary modifications. Repeat IgG food panel and GI-MAP guide protocol refinement at the 6-month mark. |
These specific, evidence-based lifestyle practices address the upstream drivers of immune hyper-reactivity — not just the symptoms.

Isotonic saline nasal irrigation with a neti pot or squeeze bottle twice daily physically removes allergen particles, mold spores, and pollutants from the nasal mucosa before they can trigger an immune response. Use sterile or distilled water (never tap water); add 0.5 teaspoon non-iodised salt and 0.25 teaspoon baking soda per 240ml. This practice reduces the allergen load reaching mast cells in the nasal epithelium and significantly reduces medication requirement in multiple randomised trials.

You spend one-third of your life in your bedroom — making it the single most important allergen environment to optimise. Encase mattress and pillows in allergen-barrier covers rated at ≤3 microns (ASTM standard); wash all bedding in hot water (≥55°C / 131°F) weekly to kill dust mites; install a HEPA air purifier rated for your room size (CADR ≥ 200 for an average bedroom); keep bedroom humidity at 40–50% using a dehumidifier (dust mites cannot survive below 50% relative humidity). These combined interventions can reduce dust mite allergen exposure by 95%.

Practice 10 minutes of 4-7-8 breathing daily: inhale through the nose for 4 counts, hold for 7 counts, exhale through the mouth for 8 counts. This specific breathing pattern activates the vagus nerve, shifts the autonomic nervous system from sympathetic (pro-inflammatory, mast-cell-priming) to parasympathetic (anti-inflammatory) dominance, and reduces circulating cortisol levels measurably. A morning session upon waking and an evening session before bed are particularly effective at recalibrating the HPA-axis diurnal pattern.

Moderate aerobic exercise (brisk walking, cycling, swimming) at 60–70% of maximum heart rate for 30–45 minutes, 4–5 days per week, produces a measurable anti-inflammatory effect by reducing circulating TNF-α and IL-6 levels and improving mucosal IgA secretion — the first line of respiratory immune defence. Crucially, high-intensity exercise (>85% max heart rate) in allergy patients can trigger exercise-induced bronchoconstriction and should be approached with caution; swimming in indoor pools (chlorinated water) is a notable trigger for some patients.

Install true HEPA filters rated at H13 or H14 (capturing ≥99.97% of particles ≥0.3 microns) in combination with activated carbon filters in all primary living areas. HEPA alone captures mold spores, pollen, dander, and dust mite particles, while activated carbon specifically adsorbs volatile organic compounds (VOCs), mycotoxins, and chemical irritants that worsen mast cell reactivity. Replace filters on schedule (typically every 6–12 months for HEPA, every 3 months for carbon). NYC residents should also monitor the daily Air Quality Index (AQI) and avoid prolonged outdoor exercise on high-pollution days.

Histamine levels are naturally elevated in the evening due to circadian variation in diamine oxidase (DAO) enzyme activity, explaining why many allergy sufferers feel worse at night. An evening anti-histamine routine includes: green tea with lemon (quercetin + vitamin C synergy for DAO support), avoiding fermented foods (wine, cheese, vinegar) after 3pm, taking DAO enzyme with the evening meal, and a sleep-time dose of magnesium glycinate (300–400mg) which has natural mast cell-stabilising properties and improves sleep quality disrupted by elevated evening histamine.
Diet powerfully modulates allergic immune reactivity through three mechanisms: reducing the antigenic load on gut mast cells, providing anti-inflammatory nutrients that lower mast cell sensitivity, and supplying cofactors essential for histamine-degrading enzyme (DAO and HMNT) function. What you eat is one of the most tractable levers for changing your allergy trajectory.
Eliminate dietary histamine-liberators and DAO-blocking foods for 4 weeks while maximising quercetin-rich and omega-3-rich foods. The combination of reducing histamine load and increasing histamine degradation capacity produces a double-action effect that lowers the baseline inflammatory state driving allergy amplification — without any medication.
General allergies rarely exist in isolation — they share immune mechanisms and frequently co-occur with these conditions, which deserve concurrent evaluation and treatment.
Allergic asthma is the most common form of asthma and shares identical IgE-mast cell mechanisms with allergic rhinitis. The “one airway, one disease” concept holds that untreated nasal allergies directly worsen bronchial hypersensitivity — treating rhinitis effectively reduces asthma exacerbations.
Food IgE allergies and delayed IgG sensitivities both contribute to gut mast cell activation and systemic immune load, directly amplifying environmental allergy severity. Identifying and eliminating food immune triggers frequently produces surprising improvements in environmental allergy symptoms.
The most severe form of immune-mediated food reaction, coeliac is an autoimmune response to gluten involving HLA-DQ2/DQ8 genetics, anti-tTG antibodies, and villous atrophy. Distinguishing coeliac from non-coeliac gluten sensitivity (IgG-mediated) is essential because the treatment intensity and dietary strictness required differ substantially.
The neuroinflammation and mitochondrial dysfunction produced by persistent allergic immune activation are major and frequently unrecognised contributors to chronic fatigue. Resolving the allergic immune burden often produces dramatic improvements in energy levels in patients with concurrent fatigue.
Mast Cell Activation Syndrome (MCAS), eosinophilic oesophagitis, and common variable immunodeficiency (CVID) all present with allergy-like symptoms but require distinct diagnostic and treatment approaches — a comprehensive functional medicine evaluation differentiates these conditions.
Chronic psychological stress directly primes mast cells for lower-threshold activation through CRH (corticotropin-releasing hormone) receptors on mast cell surfaces, explaining why allergy sufferers reliably experience worse symptoms during high-stress periods and why stress management is a medical intervention.
Many people normalise allergy symptoms for years, managing with over-the-counter antihistamines and assuming “it’s just allergies.” But chronic allergic inflammation is a significant health burden with consequences for sleep, cognition, cardiovascular health, and immune function. Seek a comprehensive functional medicine evaluation if any of the following apply to you.
🚨 Seek Emergency Medical Evaluation Immediately If: You experience throat tightness, difficulty swallowing, tongue or lip swelling, widespread hives, sudden severe wheezing, lightheadedness, or rapid heart rate after allergen exposure — these are signs of anaphylaxis, a life-threatening systemic allergic reaction. Call 911 or go to the nearest emergency room immediately. If you carry an epinephrine auto-injector (EpiPen), use it and still seek emergency evaluation. Do not wait to see if symptoms resolve on their own.
The following accounts reflect real patient experiences at Patients Medical. Names have been abbreviated to protect privacy. Individual outcomes vary.
A general allergy — also called an environmental or aeroallergen allergy — is an immune-mediated hypersensitivity reaction triggered by inhaled, contacted, or injected substances such as pollen, dust mites, pet dander, mold spores, insect venom, or latex. The immune system mistakenly identifies these harmless particles as threats and produces immunoglobulin E (IgE) antibodies against them. On subsequent exposures, these IgE antibodies bind to mast cells and basophils, triggering the release of histamine and other inflammatory mediators that produce the classic symptoms of sneezing, nasal congestion, itchy eyes, and skin reactions.
Food allergies, by contrast, involve an immune reaction specifically to food proteins — most commonly peanuts, tree nuts, shellfish, milk, eggs, wheat, soy, and fish — and can trigger systemic anaphylaxis with greater frequency than environmental allergens. A third category — food sensitivities — involves IgG-mediated or non-immunological reactions that cause delayed, low-grade inflammation rather than immediate acute symptoms.
At Patients Medical, we evaluate all three categories as part of a comprehensive allergy workup, because unidentified food sensitivities frequently amplify environmental allergy severity — a connection that standard allergy clinics rarely investigate.
The timeline for allergy relief depends heavily on the treatment approach. For conventional antihistamines and corticosteroids, symptom relief typically occurs within 30–60 minutes, but these medications do not reduce long-term immune reactivity. Allergen immunotherapy (subcutaneous injections or sublingual drops) typically requires 3–5 years of treatment, with noticeable improvement in most patients after 6–12 months.
At Patients Medical, our functional medicine protocol targets the root causes of immune dysregulation simultaneously. Patients following our gut-repair and anti-inflammatory protocols typically notice a reduction in symptom severity within 4–8 weeks, with significant improvement in immune reactivity within 3–6 months. Patients who also address concurrent mold exposure, intestinal permeability, or nutrient deficiencies tend to respond more quickly.
Complete immune recalibration — meaning a stable reduction in allergic reactivity without ongoing treatment — can take 12–24 months with a comprehensive protocol. The investment in addressing root causes, however, produces durable change rather than the indefinite symptom management required by standard approaches.
The gold standard for diagnosing IgE-mediated allergies is the specific IgE RAST panel, which measures serum antibody levels against individual allergens. A skin prick test is a complementary in-office method. However, conventional allergy testing typically only evaluates IgE-mediated reactions and misses immune reactions driven by IgG antibodies, T-cell activation, or non-immunological histamine pathways.
At Patients Medical, our comprehensive allergy evaluation includes: a specific IgE RAST panel covering 120+ environmental allergens; a comprehensive IgG food sensitivity panel (184 foods); a complete blood count with differential to assess eosinophil and basophil counts; mold and mycotoxin urine testing for patients with suspected mold exposure; and a GI-MAP stool analysis to evaluate gut microbiome health and intestinal barrier integrity.
This multi-pathway approach identifies drivers of allergic reactivity that standard allergy testing routinely misses — explaining why many patients who receive normal results on standard panels still experience significant allergy symptoms. See our allergy testing page for full details.
Yes — chronic allergies are a frequently overlooked driver of persistent fatigue and cognitive impairment. The mechanisms are multiple. Histamine is a neuroactive compound; elevated histamine levels disrupt sleep architecture in the hypothalamus, leading to non-restorative sleep. The ongoing release of pro-inflammatory cytokines — particularly IL-4, IL-13, and TNF-α — directly impairs mitochondrial function, reducing cellular energy production and producing the profound tiredness allergy sufferers describe.
Nasal congestion and post-nasal drip frequently reduce overnight oxygen saturation, exacerbating daytime fatigue and cognitive impairment. Additionally, many allergy sufferers have concurrent intestinal hyperpermeability (leaky gut), which allows bacterial lipopolysaccharides (LPS) to enter systemic circulation and activate neuroinflammatory pathways, directly producing the brain fog, word-finding difficulties, and reduced processing speed that patients often attribute to stress or ageing.
At Patients Medical, we assess fatigue and cognitive symptoms in the context of the full allergy and immune picture. Resolving the underlying allergic drivers often produces dramatic improvements in energy and mental clarity — effects patients frequently describe as more transformative than their physical allergy symptom relief.
Allergic rhinitis and acute sinusitis can produce nearly identical symptoms — nasal congestion, facial pressure, post-nasal drip, and fatigue — but they differ fundamentally in cause, duration, and treatment. Allergic rhinitis produces thin, watery, clear nasal discharge; itching of the nose, eyes, and throat; and sneezing. It follows a seasonal or perennial pattern, does not typically cause fever, and does not respond to antibiotics.
Acute bacterial sinusitis produces thick, coloured nasal discharge, facial pain over the sinuses, and often fever. It typically develops after a cold or upper respiratory infection and resolves with appropriate antibiotics. Importantly, untreated allergic rhinitis is the leading risk factor for recurrent sinusitis — the inflammation and mucus accumulation created by allergic reactions provide an ideal environment for bacterial overgrowth in the paranasal sinuses.
At Patients Medical, we routinely assess patients with recurrent sinusitis for underlying allergic drivers that perpetuate the cycle. Treating the allergy root cause is frequently more effective at preventing sinusitis recurrence than repeated antibiotic courses, which further disrupt the gut microbiome and compound the original problem.
The gut microbiome plays a central role in immune system education and allergic disease. The “old friends hypothesis” proposes that reduced early-life exposure to diverse microbial organisms — through antibiotic use, formula feeding, caesarean birth, and overly sanitised environments — impairs the development of immune regulatory T-cells (Tregs) that normally suppress allergic IgE responses.
Without adequate Treg activity, the immune system defaults toward a Th2 (pro-allergic) phenotype characterised by excessive IgE production and mast cell activation. Additionally, intestinal barrier dysfunction — leaky gut — allows incompletely digested food proteins and bacterial endotoxins to enter systemic circulation, triggering immune sensitisation that manifests as both food and environmental allergies.
The gut microbiome also directly regulates systemic histamine levels through the enzyme diamine oxidase (DAO); low DAO activity — associated with dysbiosis and nutrient deficiencies — impairs histamine breakdown and contributes to a chronic high-histamine state. At Patients Medical, restoring gut microbiome diversity and intestinal barrier integrity is the cornerstone of our allergy treatment protocol. See Leaky Gut Treatment for more detail.
Several evidence-based nutraceuticals have demonstrated significant efficacy in modulating allergic immune responses. Quercetin (500–1000 mg daily) inhibits mast cell degranulation and histamine release, functioning as a natural mast cell stabiliser. Vitamin C (1000–3000 mg daily) acts as a natural antihistamine by increasing enzymatic breakdown of histamine. Butterbur extract (standardised to 8 mg petasines) has been shown in randomised controlled trials to reduce nasal allergy symptoms comparably to cetirizine.
Bromelain (400–500 mg daily), derived from pineapple, reduces nasal inflammation and improves sinus drainage. Probiotics containing Lactobacillus rhamnosus GG and Lactobacillus acidophilus have demonstrated reductions in allergic rhinitis severity in multiple clinical trials. Diamine oxidase (DAO) enzyme supplementation supports histamine breakdown in patients with documented DAO deficiency. Vitamin D (maintain serum 25-OH-D at 60–80 ng/mL) is essential for Treg differentiation. Omega-3 fatty acids (EPA + DHA, 2–3 g daily) reduce mast cell sensitivity by shifting prostaglandin synthesis away from pro-inflammatory PGE2.
At Patients Medical, all supplement protocols are individualised based on comprehensive testing results — including IgG food panels, nutrient levels, and microbiome analysis — rather than generic recommendations. See our allergy treatments page for more information.
At Patients Medical, we don’t just manage allergy symptoms — we map the full landscape of your immune reactivity and build a personalised protocol to address every identified driver, from gut microbiome to mold exposure to nutrient deficiencies.
IgE RAST panel, IgG food sensitivity, GI-MAP, mycotoxin, and nutrient analysis — the most complete allergy picture available in NYC.
Dr. Rashmi Gulati and our team translate complex immune data into a clear, prioritised treatment protocol built for your specific biology.
Repeat biomarker testing at 3 and 6 months quantifies your immune improvement and guides protocol refinement for lasting results.
Call us at (212) 794-8800 · 800 Second Avenue, Suite 900, New York, NY 10017
Patients Medical specializes in gently helping the patient identify the root cause of their medical issues and then assist them to recover from their problems to help them move forward to good health.
To schedule an in person on Tele-medicine appointment, please call our office at (212) 794-8800 or email us at info@PatientsMedical.com We look forward to hearing from you
Patients Medical PC
1148 Fifth Avenue, Suite 1B New York, NY 10128
Copyright © 2025 Patients Medical. All Rights Reserved.
All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease. Patients Medical.